Menu
Solutions
Solutions
Solutions for Integrated Delivery Networks
Solutions for Community Cancer Centers
Solutions for Academic Institutions and NCI-Designated Cancer Centers
Solutions for Life Science
Resources
Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Solutions
Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Next Level
Multidisciplinary Cancer Care
Explore the OncoLens Platform
Resources
Project ECHO® Learning Series
Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
LEARN MORE and REGISTER
Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
Powered by OncoLens.
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
2,000,000+
Patients under Care in 200+ Cancer Centers
143,000+
Multidisciplinary Case Discussions
24,000+
Comprehensive Tumor Conferences
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Careers
Solutions
Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Next Level
Multidisciplinary Cancer Care
Explore the OncoLens Platform
Resources
Project ECHO® Learning Series
Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
LEARN MORE and REGISTER
Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
Powered by OncoLens.
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
2,000,000+
Patients under Care in 200+ Cancer Centers
118,000+
Multidisciplinary Case Discussions
19,000+
Comprehensive Tumor Conferences
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
SCHEDULE A DEMO
Home
Resources
EGFR
EGFR
Epidermal growth factor receptor (EGFR).
Other Topics:
ATM
(2)
BRCA
(2)
Breast Cancer
(2)
cancer care affiliate networks
(1)
cardiovascular
(1)
CDK12
(2)
clinical trial recruitment
(1)
CoC
(1)
dermatology
(1)
EGFR
(8)
endocrinology
(1)
Exon 19 Deletion
(4)
Gastric Cancer
(3)
gastroenterology
(1)
hepatology
(1)
high grade glioma
(2)
immunotherapy
(8)
irAE
(8)
KIT Exon 11
(2)
Lung Cancer
(10)
neurology
(1)
NSCLC
(9)
Ovarian Cancer
(3)
Prostate Cancer
(2)
rheumatology
(1)
Lung Cancer Patient with 3 EGFR Mutations
Topics —
EGFR
,
Lung Cancer
Apr 1, 2021
|
Education
Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations
Topics —
BRCA
,
EGFR
,
Lung Cancer
,
Ovarian Cancer
Apr 1, 2021
|
Education
NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Mar 1, 2021
|
Education
Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
Mar 1, 2021
|
Education
NSCLC Patient and Adjuvant Chemotherapy
Topics —
EGFR
,
Lung Cancer
,
NSCLC
Mar 1, 2021
|
Education
Patient with NSCLC Who Recurred within a Year
Topics —
EGFR
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education